Reporte zur Charge GNG204

Symptomtext

Diarrhea; Fatigue; ache; This is a spontaneous report received from a contactable consumer, the patient. A 69-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: GNG204) via an unspecified route of administration in left arm on 18Mar2021 at 14:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid, prostate cancer, cholesterol and blood pressure. The patient had allergies to sulfur. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received medications (unknown) within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ENG198) via an unspecified route of administration in left arm on 25Feb2021 at 15:30 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. On 19Mar2021, the patient experienced diarrhoea, fatigue and ache. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events diarrhoea, fatigue and ache was not resolved at the time of this report. No follow up attempts are needed. No further information is expected.